The acetylation levels of histones at histone gene promoters decrease in cells with p300 knockdown. by Hongpeng He (348094)

“…HeLa cells were treated with 2.5 mM of HU for 24 hours before being harvested. …”

Fig 4 - by Chengyu Wu (640314)

Subjects:

Fig 1 - by Chengyu Wu (640314)

Subjects:

A647D decreased mexiletine sensitivity of P1332L when coexpressed. by Jie Liu (15128)

Ameliorative effect of yokukansan on glutamate-induced decrease in GSH levels in PC12 cells. by Hitomi Kanno (584976)

C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

“…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”

C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

“…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”

C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

“…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”

C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

“…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”

C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion by Yunwei Shi (10116568)

“…Here, we determined whether C5aR1 signaling was essential to the post-ischemic inflammation and brain injury and whether it is a valid target for therapeutic blockade by using soluble receptor antagonist PMX53 in the early stage after I/R injury. …”

Reduced autophagy, decreased survival, larger infarct areas, compromised cardiac function and contraction, and impaired angiogenesis in <i>AGGF1</i>^<i>+/-</i> knockout m... by Qiulun Lu (302045)

Silymarin disrupted insulin signaling to decrease glucose uptake in L6 myotube cells. by Kai-Chun Cheng (441773)

S1P antibodies decrease S1P- and 4-Deoxypyridoxine-induced HPAEC migration. by Evgeny V. Berdyshev (307465)

Particle Morphology Evolution and Its Enhancement for Lignite Gasification in Supercritical Water by Rui Zhang (13940)

Subjects:

S1 Data - by Jordan A. Gunning (18143970)

“…Specifically, total immune cells (CD45+) decrease at days 2 and 5 following IR, macrophages (F4/80+CD11b+) decrease at day 2 and 5 and increase at day 30, while neutrophils (Ly6G+CD11b+) significantly increase at day 30 following IR. …”

Decrease of the DXR-induced genotoxicity and nongenotoxic effects of Theobroma cacao revealed by micronucleus assay by M. F. G. Boriollo (4894975)

Complex I activity is increased in cells with elevated NQO1 levels and is decreased by rotenone. by Jiyeong Kim (433042)

Novel site-specific PEGylated L-asparaginase by Giovanna Pastore Meneguetti (6325571)

Subjects:

SARS-CoV-2 genome sequencing metrics. by Ludy R. Carmola (20978107)

“…We investigated viral and host factors, including vaccination status, that were associated with SARS-CoV-2 disease severity in a setting with low vaccination rates. …”

SARS-CoV-2 variants by vaccination status. by Ludy R. Carmola (20978107)

“…We investigated viral and host factors, including vaccination status, that were associated with SARS-CoV-2 disease severity in a setting with low vaccination rates. …”